Regional Health Financials
Regional Health (RHEP) reported $53.2M in revenue for fiscal year 2025, up 189.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Reported profit looks more like a transaction-driven rebound than a clean improvement in cash earnings.
The latest year produced positive net income of$3.4M even though operating cash flow was-$2.3M , so the earnings recovery did not convert into cash. That mismatch matters because operating income of$1.7M still sat below interest expense of$2.7M , implying the year depended on items outside the normal operating run rate.
Revenue reached
Leverage has eased somewhat, with long-term debt down to
Financial Health Signals
We are recalculating Regional Health's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.
Regional Health scores -0.92, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($4.0M) relative to total liabilities ($62.8M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Regional Health passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Regional Health used $0.67 of operating cash (-$2.3M OCF vs $3.4M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Regional Health earns $0.62 in operating income for every $1 of interest expense ($1.7M vs $2.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Regional Health generated $53.2M in revenue in fiscal year 2025. This represents an increase of 189.9% from the prior year.
Regional Health's EBITDA was $3.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 67.7% from the prior year.
Regional Health reported $3.4M in net income in fiscal year 2025. This represents an increase of 204.7% from the prior year.
Cash & Balance Sheet
Regional Health recorded an outflow of $3.1M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 321.4% from the prior year.
Regional Health held $3.0M in cash against $34.7M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Regional Health's gross margin was 86.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs.
Regional Health's operating margin was 3.1% in fiscal year 2025, reflecting core business profitability. This is up 2.3 percentage points from the prior year.
Regional Health's net profit margin was 6.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 23.9 percentage points from the prior year.
Regional Health's ROE was 965.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.
Capital Allocation
Regional Health invested $869K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 64.0% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
RHEP Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $67.1M | $53.2M+189.9% | $18.3M+6.8% | $17.2M-52.2% | $35.9M+34.6% | $26.7M+51.8% | $17.6M-12.7% | $20.1M-8.7% | $22.0M-12.3% | $25.1M-8.9% | $27.6M+50.0% | $18.4M+453.4% | $3.3M-98.2% | $185.8M-4.3% | $194.1M+40.4% | $138.2M |
| Cost of Revenue | N/A | $7.0M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | $46.2M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $16.3M | $12.0M+122.7% | $5.4M-0.1% | $5.4M+16.3% | $4.7M+18.3% | $3.9M+16.5% | $3.4M+5.7% | $3.2M-13.5% | $3.7M-4.2% | $3.9M-50.0% | $7.7M-26.8% | $10.5M-32.8% | $15.7M-17.5% | $19.0M+11.9% | $17.0M+28.0% | $13.3M |
| Operating Income | $1.3M | $1.7M+933.5% | $161K+119.6% | -$821K+88.0% | -$6.8M-369.3% | $2.5M+10.4% | $2.3M-58.0% | $5.5M+789.6% | -$792K-115.4% | $5.1M+13.7% | $4.5M+159.1% | -$7.6M+68.4% | -$24.2M-1383.6% | -$1.6M-159.9% | $2.7M+145.5% | $1.1M |
| Interest Expense | $2.5M | $2.7M-1.4% | $2.7M-1.5% | $2.8M+8.8% | $2.5M-5.2% | $2.7M-3.9% | $2.8M-47.3% | $5.3M-11.2% | $5.9M+44.8% | $4.1M-42.7% | $7.1M-15.5% | $8.5M-20.7% | $10.7M-13.6% | $12.4M-2.6% | $12.7M+71.9% | $7.4M |
| Income Tax | N/A | $108K | N/A | N/A | N/A | N/A | N/A | $0+100.0% | -$38K+79.8% | -$188K-15.3% | -$163K-248.2% | $110K-16.0% | $131K-7.7% | $142K+46.4% | $97K-54.9% | $215K |
| Net Income | $3.4M | $3.4M+204.7% | -$3.2M+17.2% | -$3.9M+43.4% | -$6.9M-481.0% | -$1.2M-71.8% | -$688K-112.5% | $5.5M+146.2% | -$11.9M-1107.6% | -$985K+86.8% | -$7.5M+68.3% | -$23.5M-72.9% | -$13.6M-8.2% | -$12.6M-82.6% | -$6.9M-11.7% | -$6.2M |
| EPS (Diluted) | — | $1.09 | -$1.73-108.2% | $21.05+335.7% | -$8.93 | -$5.87 | N/A | N/A | N/A | N/A | -$0.74 | -$1.46-62.2% | -$0.90+4.3% | -$0.94-88.0% | -$0.50+15.3% | -$0.59 |
Not reported in any period shown, so not listed: R&D Expenses.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
RHEP Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $67.8M+12.1% | $60.5M-2.8% | $62.2M-9.3% | $68.6M-35.1% | $105.7M-2.2% | $108.0M-5.0% | $113.8M+13.1% | $100.6M-5.6% | $106.6M-10.8% | $119.5M-29.4% | $169.3M-19.4% | $210.0M-7.3% | $226.4M-3.7% | $235.2M+47.9% | $159.1M |
| Current Assets | $16.3M+138.8% | $6.8M | N/A | N/A | N/A | N/A | $7.4M-8.4% | $8.1M+71.7% | $4.7M-77.0% | $20.5M-18.6% | $25.2M-55.9% | $57.0M-3.0% | $58.7M+13.1% | $51.9M+80.7% | $28.7M |
| Cash & Equivalents | $3.0M+415.5% | $582K-41.8% | $1.0M+25.0% | $800K-88.2% | $6.8M+61.9% | $4.2M-4.5% | $4.4M+83.3% | $2.4M+32.0% | $1.8M-87.1% | $14.0M+416.4% | $2.7M-74.7% | $10.7M-44.6% | $19.4M+21.6% | $15.9M+116.4% | $7.4M |
| Inventory | $1.4M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $8.0M+138.7% | $3.4M+140.1% | $1.4M-77.7% | $6.3M+193.2% | $2.1M+2.1% | $2.1M+110.0% | $1.0M0.0% | $1.0M+5.8% | $945K-61.1% | $2.4M-72.4% | $8.8M-63.8% | $24.3M+2.9% | $23.6M-12.1% | $26.8M+42.9% | $18.8M |
| Goodwill | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M-24.7% | $2.1M0.0% | $2.1M0.0% | $2.1M-49.7% | $4.2M-1.0% | $4.2M0.0% | $4.2M-15.9% | $5.0M+39.5% | $3.6M |
| Total Liabilities | $62.8M-1.0% | $63.4M+2.2% | $62.0M-4.4% | $64.9M-31.9% | $95.3M-1.7% | $96.9M-5.0% | $102.0M+8.0% | $94.4M+6.5% | $88.7M-43.7% | $157.4M-18.5% | $193.1M+3.7% | $186.2M-6.5% | $199.1M-5.6% | $211.0M+46.9% | $143.6M |
| Current Liabilities | $24.2M+18.4% | $20.4M | N/A | N/A | N/A | N/A | $14.1M-61.6% | $36.7M+88.3% | $19.5M-22.8% | $25.3M-60.4% | $63.8M-7.9% | $69.3M+0.1% | $69.2M+21.3% | $57.1M+67.4% | $34.1M |
| Long-Term Debt | $34.7M-11.6% | $39.3M-22.6% | $50.7M-2.8% | $52.2M-1.3% | $52.9M-2.9% | $54.4M-1.7% | $55.4M-31.9% | $81.3M+25.1% | $65.0M-2.7% | $66.8M-5.7% | $70.8M | N/A | N/A | N/A | N/A |
| Total Equity | $349K+112.0% | -$2.9M-1677.8% | $185K-95.0% | $3.7M-64.3% | $10.4M-6.4% | $11.1M-5.4% | $11.7M+90.9% | $6.2M-65.6% | $17.9M+147.1% | -$37.9M-59.2% | -$23.8M-508.9% | $5.8M-31.3% | $8.5M-46.6% | $15.9M-2.7% | $16.3M |
| Retained Earnings | -$81.8M+3.9% | -$85.1M-3.9% | -$81.9M+32.5% | -$121.4M-6.0% | -$114.5M-1.0% | -$113.4M-0.6% | -$112.7M+4.7% | -$118.2M-11.2% | -$106.3M-6.7% | -$99.6M-17.5% | -$84.8M-51.2% | -$56.1M-40.6% | -$39.9M-54.9% | -$25.8M-37.6% | -$18.7M |
RHEP Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$3.4M | -$2.3M-216.3% | $1.9M-47.7% | $3.7M+203.2% | -$3.6M-173.5% | $4.9M+277.9% | $1.3M-46.0% | $2.4M+77.7% | $1.3M-73.8% | $5.1M+250.9% | -$3.4M+80.9% | -$17.8M-190.2% | -$6.1M-221.2% | $5.1M+249.9% | $1.4M-27.4% | $2.0M |
| Capital Expenditures | $1.2M | $869K+64.0% | $530K-44.7% | $958K+240.9% | $281K+128.5% | $123K-72.7% | $450K+675.9% | $58K-82.8% | $338K-60.0% | $846K-43.6% | $1.5M-16.6% | $1.8M-56.5% | $4.1M-8.4% | $4.5M-19.5% | $5.6M+32.3% | $4.2M |
| Free Cash Flow | -$4.6M | -$3.1M-321.4% | $1.4M-48.7% | $2.8M+171.0% | -$3.9M-181.3% | $4.8M+464.6% | $845K-63.9% | $2.3M+131.5% | $1.0M-76.5% | $4.3M+187.6% | -$4.9M+75.0% | -$19.6M-90.8% | -$10.3M-1992.1% | $543K+113.0% | -$4.2M-85.0% | -$2.3M |
| Investing Cash Flow | $14.8M | $15.1M+2949.4% | -$530K+44.7% | -$958K-240.9% | -$281K-128.5% | -$123K+72.7% | -$450K-111.8% | $3.8M+1230.5% | -$338K+85.1% | -$2.3M-109.4% | $24.1M+145.1% | $9.8M+8387.1% | $116K+103.7% | -$3.1M+94.7% | -$59.2M+3.0% | -$61.0M |
| Financing Cash Flow | -$10.4M | -$10.3M-382.4% | -$2.1M+14.3% | -$2.5M-20.2% | -$2.1M+14.6% | -$2.4M-73.6% | -$1.4M+70.2% | -$4.7M-4087.2% | $117K+100.7% | -$17.0M-81.2% | -$9.4M-17305.6% | -$54K+97.9% | -$2.6M-275.0% | $1.5M-97.7% | $66.5M+6.4% | $62.5M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0-100.0% | $3.3M | $0 | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | $46K+557.1% | $7K | N/A | N/A | N/A | $186K-64.4% | $523K | $0 | N/A | N/A | N/A | N/A |
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
RHEP Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.9% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | 3.1%+2.3pp | 0.9%+5.7pp | -4.8%+14.2pp | -19.0%-28.5pp | 9.5%-3.6pp | 13.1%-14.1pp | 27.1%+30.7pp | -3.6%-24.0pp | 20.4%+4.1pp | 16.4%+57.9pp | -41.5% | -727.8% | -0.9%-2.3pp | 1.4%+0.6pp | 0.8% |
| Net Margin | 6.3%+23.9pp | -17.5%+5.1pp | -22.7%-3.5pp | -19.1%-14.7pp | -4.4%-0.5pp | -3.9%-31.2pp | 27.3%+81.3pp | -54.0%-50.0pp | -3.9%+23.1pp | -27.0% | -127.8% | -409.0% | -6.8%-3.2pp | -3.5%+0.9pp | -4.5% |
| Return on Equity | 965.6% | N/A | -2101.6%-1916.8pp | -184.8%-173.4pp | -11.4%-5.2pp | -6.2%-53.0pp | 46.8%+240.2pp | -193.4%-187.9pp | -5.5% | N/A | N/A | -233.3%-85.2pp | -148.1%-104.8pp | -43.3%-5.6pp | -37.7% |
| Return on Assets | 5.0%+10.3pp | -5.3%+0.9pp | -6.3%+3.8pp | -10.0%-8.9pp | -1.1%-0.5pp | -0.6%-5.5pp | 4.8%+16.7pp | -11.8%-10.9pp | -0.9%+5.3pp | -6.3%+7.6pp | -13.9%-7.4pp | -6.5%-0.9pp | -5.5%-2.6pp | -2.9%+0.9pp | -3.9% |
| Current Ratio | 0.67+0.3x | 0.33 | N/A | N/A | N/A | N/A | 0.52+0.3x | 0.220.0x | 0.24-0.6x | 0.81+0.4x | 0.39-0.4x | 0.820.0x | 0.85-0.1x | 0.91+0.1x | 0.84 |
| Debt-to-Equity | 99.54 | N/A | 274.24+260.2x | 14.04+9.0x | 5.09+0.2x | 4.90+0.2x | 4.71-8.5x | 13.22+9.6x | 3.64 | N/A | N/A | 31.94+8.5x | 23.47+10.2x | 13.28+4.5x | 8.79 |
| FCF Margin | -5.9%-13.6pp | 7.7%-8.3pp | 16.1%+26.8pp | -10.8%-28.7pp | 17.9%+13.1pp | 4.8%-6.8pp | 11.6%+7.0pp | 4.6%-12.5pp | 17.1%+34.9pp | -17.8% | -106.5% | -309.0% | 0.3%+2.4pp | -2.1%-0.5pp | -1.6% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Note: The current ratio is below 1.0 (0.67), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where Regional Health Ranks
Frequently Asked Questions
What is Regional Health's annual revenue?
Regional Health (RHEP) reported $53.2M in total revenue for fiscal year 2025. This represents a 189.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Regional Health's revenue growing?
Regional Health (RHEP) revenue grew by 189.9% year-over-year, from $18.3M to $53.2M in fiscal year 2025.
Is Regional Health profitable?
Yes, Regional Health (RHEP) reported a net income of $3.4M in fiscal year 2025, with a net profit margin of 6.3%.
What is Regional Health's EBITDA?
Regional Health (RHEP) had EBITDA of $3.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Regional Health have?
As of fiscal year 2025, Regional Health (RHEP) had $3.0M in cash and equivalents against $34.7M in long-term debt.
What is Regional Health's gross margin?
Regional Health (RHEP) had a gross margin of 86.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Regional Health's operating margin?
Regional Health (RHEP) had an operating margin of 3.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Regional Health's net profit margin?
Regional Health (RHEP) had a net profit margin of 6.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Regional Health's return on equity (ROE)?
Regional Health (RHEP) has a return on equity of 965.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Regional Health's free cash flow?
Regional Health (RHEP) recorded an outflow of $3.1M in free cash flow during fiscal year 2025. This represents a -321.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Regional Health's operating cash flow?
Regional Health (RHEP) recorded an outflow of $2.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Regional Health's total assets?
Regional Health (RHEP) had $67.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Regional Health's capital expenditures?
Regional Health (RHEP) invested $869K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Regional Health's current ratio?
Regional Health (RHEP) had a current ratio of 0.67 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Regional Health's debt-to-equity ratio?
Regional Health (RHEP) had a debt-to-equity ratio of 99.54 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Regional Health's return on assets (ROA)?
Regional Health (RHEP) had a return on assets of 5.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Regional Health's cash runway?
Based on fiscal year 2025 data, Regional Health (RHEP) had $3.0M in cash against an annual operating cash burn of $2.3M. This gives an estimated cash runway of approximately 16 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Regional Health's Altman Z-Score?
Regional Health (RHEP) has an Altman Z-Score of -0.92, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Regional Health's Piotroski F-Score?
Regional Health (RHEP) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Regional Health's earnings high quality?
For every $1 of reported earnings, Regional Health (RHEP) used $0.67 of operating cash (-$2.3M OCF vs $3.4M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Regional Health cover its interest payments?
Regional Health (RHEP) has an interest coverage ratio of 0.62x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.